Posts by: Patricia Inacio, PhD

Actelion Ltd, a biopharmaceutical company developing innovative therapeutics for orphan diseases, submitted a Marketing Authorization Application (MAA) for their lead investigational drug selexipag (Uptravi®) to the European Medicines Agency (EMA) as a new therapeutic for ... Read more

December 4, 2014November 11, 2015

New COPD Studies Needed To Determine Effects of Reduced Physical Capacity on Patient Outcomes

COPD, News

A new review entitled “Determinants and outcomes of physical activity in patients with COPD: a systematic review” summarizes data from recent studies on the role of physical activity in patient ... Read more

December 4, 2014November 6, 2015

New Study on Fixed Airways Obstruction Among Patients With Severe Asthma Sheds Light Risk Factors For Asian Patients

Asthma, News

A new study entitled “Fixed airways obstruction among patients with severe asthma: findings from the Singapore General Hospital-Severe Asthma Phenotype Study” identified risk factors associated with fixed obstruction airways in ... Read more

December 3, 2014November 11, 2015

COPD, Asthma Treatment Aided By Computerized Clinical Decision Support Systems

COPD, News

A new review study entitled “Effectiveness of computerized clinical decision support systems for asthma and chronic obstructive pulmonary disease in primary care: a systematic review” summarizes the impact of Computerized ... Read more

December 1, 2014November 5, 2015

Lipids in the Lungs Found To Be Pulmonary Fibrosis Cause

Idiopathic Pulmonary Fibrosis, News

A recent study entitled “A Pneumocyte-macrophage Paracrine Lipid Axis Drives the Lung Toward Fibrosis” reports an increased accumulation of lipids in lung tissue triggers pulmonary fibrosis. The study was published ... Read more

November 28, 2014November 11, 2015

European Union Approves New Chronic Obstructive Pulmonary Disease Drug

COPD, News

AstraZeneca announced that the European Commission granted their lead drug, Duaklir® Genuair®, marketing authorization as a maintenance bronchodilator treatment for adult patients with chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease (COPD) ... Read more

November 28, 2014November 5, 2015

Phase III Clinical Trial Will Test Drug For Exocrine Pancreatic Insufficiency Associated With CF

Cystic Fibrosis, News

Anthera Pharmaceuticals, Inc. announced a new agreement with DPx Holdings B.V. who will utilize their subdivision Patheon to support the manufacturing of Anthera’s lead drug Sollpura® for their upcoming Phase III clinical trial ... Read more

November 25, 2014November 25, 2014

New Bronchiolitis Treatment Strategy Targets Wheezing in Infants

Bronchiolitis, News

A recent study published in The Journal of Allergy and Clinical Immunology entitled, “Randomized trial to evaluate azithromycin’s effects on serum and upper airway IL-8 levels and recurrent wheezing in infants ... Read more

November 20, 2014November 11, 2015

Antibiotic Use for Lung Infections Could Be Reduced Thanks To New Test

COPD, News

ProACT (Procalcitonin Antibiotic Consensus Trial) is a new multicenter trial being launched to study if a new blood biomarker test can be used in clinics to determine the cause of ... Read more

November 19, 2014November 5, 2015

Carbon Monoxide Could Play Key Role in Killing Bacterial Lung Infections

Cystic Fibrosis, News

In a new study entitled “Macrophages sense and kill bacteria through carbon monoxide–dependent inflammasome activation” the authors discovered that carbon monoxide (CO) released by macrophages is a key factor in the host defense against pathogens. ... Read more